Cargando…
Protocol for a randomised controlled trial of VAsopressin versus Noradrenaline as Initial therapy in Septic sHock (VANISH)
INTRODUCTION: Vasopressin is an alternative vasopressor in the management of septic shock. It spares catecholamine use but whether it improves outcome remains uncertain. Current evidence suggests that it may be most effective if used early and possibly in conjunction with corticosteroids. This trial...
Autores principales: | Gordon, Anthony C, Mason, Alexina J, Perkins, Gavin D, Ashby, Deborah, Brett, Stephen J |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4091463/ https://www.ncbi.nlm.nih.gov/pubmed/24993769 http://dx.doi.org/10.1136/bmjopen-2014-005866 |
Ejemplares similares
-
Are large randomised controlled trials in severe sepsis and septic shock statistically disadvantaged by repeated inadvertent underestimates of required sample size?
por: Wong, Joshua L C, et al.
Publicado: (2018) -
Study into the reversal of septic shock with landiolol (beta blockade): STRESS-L Study protocol for a randomised trial
por: Lall, Ranjit, et al.
Publicado: (2021) -
Fluids in Sepsis and Septic Shock (FISSH): protocol for a pilot randomised controlled trial
por: Rochwerg, Bram, et al.
Publicado: (2017) -
Effect of levosimendan on mortality in severe sepsis and septic shock: a meta-analysis of randomised trials
por: Chang, Wei, et al.
Publicado: (2018) -
Mortality Reduction in Septic Shock by Plasma Adsorption (ROMPA): a protocol for a randomised clinical trial
por: Colomina-Climent, Francisco, et al.
Publicado: (2016)